STK11 and non-small cell lung carcinoma: LKB1 loss suppresses DPP4 expression in KL-NSCLC; however, restoring DPP4 expression in vitro promotes NK-cell recruitment, mitigating the immunosuppressive TME and enhancing the efficacy of anti–PD-1 therapy in KL models.